Senior Director, Medical Affairs

Capricor Therapeutics(1 month ago)

HybridFull TimeDirector$204,827 - $270,589 (estimated)Medical Affairs

About this role

The Senior Director of Medical Affairs at Capricor Therapeutics will lead the development and maturation of the medical affairs function for late-stage cell therapy programs, including deramiocel for Duchenne muscular dystrophy. The role is responsible for shaping the company’s scientific narrative and value proposition, and aligning medical strategy with clinical and commercial objectives. This position will serve as a key bridge between clinical development and commercialization, ensuring scientific rigor and compliant stakeholder engagement. It operates within a mission-driven biotechnology environment focused on rare diseases and cell/exosome-based therapies.

View Original Listing

Required Skills

Medical Affairs Strategy
Evidence Generation
Scientific Exchange
Stakeholder Engagement
KOL Management
Patient Advocacy Relations
Regulatory Compliance
Scientific Communications
Publications Management
Congress Planning

+15 more

Qualifications

About Capricor Therapeutics

capricor.com

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a San Diego–based biotechnology company developing cell- and exosome-based therapeutics for muscular and other select diseases. Its lead candidate, deramiocel (CAP‑1002), is an allogeneic cell therapy currently in Phase 3 clinical development for Duchenne muscular dystrophy. Capricor is also advancing exosome technology as a next‑generation platform, engineering exosomes to deliver nucleic acids and proteins to treat or prevent a variety of diseases. The company focuses on translating these platforms into novel therapeutic and preventive products.